Keep-ING balance: tumor suppression by epigenetic regulation

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Cancer arises from genetic and epigenetic alterations affecting gene expression.
• Epigenetic silencing of key genes promotes neoplastic transformation.
• ING (inhibitor of growth) proteins are crucial regulators involved in various cellular processes.

Purpose of the Study:

• To review the roles of ING proteins in cancer development.
• To highlight the epigenetic mechanisms regulated by ING proteins.
• To discuss the potential of ING proteins as biomarkers and therapeutic targets.

Main Methods:

• Literature review of studies on ING proteins and cancer.
• Analysis of epigenetic regulatory pathways involving ING proteins.
• Evaluation of ING proteins in the context of the Hallmarks of Cancer.

Main Results:

• ING proteins (ING1-ING5) function as growth regulators and chromatin modifiers.
• They interact with HDAC and HAT complexes, influencing gene expression.
• ING proteins differentially impact the Hallmarks of Cancer via epigenetic mechanisms.

Conclusions:

• ING proteins are versatile regulators with significant roles in tumorigenesis.
• Their involvement in epigenetic gene regulation presents therapeutic opportunities.
• ING proteins hold promise as biomarkers and targets for epigenetic cancer therapies.